Nicholas Lydon

CIK 1639935 · last filed 2024-06-14

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$15.48M

Companies

2

Total Filings

28

Lifetime Open-Market Net

-$16.45M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Blueprint Medicines Corp (BPMC) Delisted Director 58,026 $129.46 $7.51M -$13.83M 22 2024-06-14
ANAB Director 276,131 $56.07 $15.48M -$2.62M 6 2019-02-11

Recent Filings · Page 3 of 3

28 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-03-02 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −25,000 -$2.20M EDGAR
2018-02-20 ANAB Exer (M) +16,483 $75.0K EDGAR
2018-02-06 ANAB Grant (A) $0 EDGAR
2017-06-23 Blueprint Medicines Corp (BPMC) Delisted Grant (A) $0 EDGAR
2017-03-16 Blueprint Medicines Corp (BPMC) Delisted Sell (S) −70,000 -$2.80M EDGAR
2017-02-28 ANAB Grant (A) $0 EDGAR
2017-01-31 ANAB Mixed +220,291 $250.0K EDGAR
2016-06-27 Blueprint Medicines Corp (BPMC) Delisted Grant (A) $0 EDGAR
Showing 2128 of 28
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.